Effect of RTS,S/AS01
Journal
NPJ vaccines
ISSN: 2059-0105
Titre abrégé: NPJ Vaccines
Pays: England
ID NLM: 101699863
Informations de publication
Date de publication:
25 Oct 2024
25 Oct 2024
Historique:
received:
08
05
2024
accepted:
19
09
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
25
10
2024
Statut:
epublish
Résumé
RTS,S/AS01
Identifiants
pubmed: 39455625
doi: 10.1038/s41541-024-00977-y
pii: 10.1038/s41541-024-00977-y
doi:
Types de publication
Journal Article
Langues
eng
Pagination
200Informations de copyright
© 2024. The Author(s).
Références
World Health Organization. WHO recommends groundbreaking malaria vaccine for children at risk. https://www.who.int/news/item/06-10-2021-who-recommends-groundbreaking-malaria-vaccine-for-children-at-risk .
Garçon, N. & Van Mechelen, M. Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems. Expert Rev. Vaccines 10, 471–486 (2011).
doi: 10.1586/erv.11.29
pubmed: 21506645
Laurens, M. B.RTS,S/AS01 vaccine (Mosquirix
McCall, M. B. B., Kremsner, P. G. & Mordmüller, B. Correlating efficacy and immunogenicity in malaria vaccine trials. Semin Immunol. 39, 52–64 (2018).
doi: 10.1016/j.smim.2018.08.002
pubmed: 30219621
White, M. T. et al. Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. Lancet Infect Dis 15, https://doi.org/10.1016/S1473-3099(15)00239-X (2015).
Ubillos, I. et al. Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children. BMC Med 16, 197 (2018).
doi: 10.1186/s12916-018-1186-4
pubmed: 30376866
pmcid: 6208122
Dobaño, C. et al. Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy. Nat Commun.10, https://doi.org/10.1038/s41467-019-10195-z (2019).
RTS SCTP. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet.386, https://doi.org/10.1016/S0140-6736(15)60721-8 (2015).
Sanchez, L. et al. Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique. npj Vaccines 5, 1–16 (2020).
Sun, P. et al. Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ. J. Immunol. 171, 6961–6967 (2003).
doi: 10.4049/jimmunol.171.12.6961
pubmed: 14662904
Kester, K. E. et al. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: Safety, efficacy, and immunologic associates of protection. J. Infect. Dis. 200, 337–346 (2009).
doi: 10.1086/600120
pubmed: 19569965
Lumsden, J. M. et al. Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-α producing effector and central memory CD4 + T cells. PLoS One 2011;6, https://doi.org/10.1371/journal.pone.0020775 . (2011).
Barbosa, A. et al. Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique. Infect. Immun. 77, 4502–4509 (2009).
doi: 10.1128/IAI.00442-09
pubmed: 19651872
pmcid: 2747951
Olotu A. et al. Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01 E and protection against P falciparum clinical malaria. PLoS One. 6, https://doi.org/10.1371/journal.pone.0025786 (2011).
Ndungu, F. M. et al. A Statistical Interaction between Circumsporozoite Protein-Specific T Cell and Antibody Responses and Risk of Clinical Malaria Episodes following Vaccination with RTS,S/AS01E. PLoS One.7, https://doi.org/10.1371/journal.pone.0052870 (2012).
Moncunill, G. et al. Distinct helper t cell type 1 and 2 responses associated with malaria protection and risk in rts,s/as01e vaccinees. Clin. Infect. Dis. 65, 746–755 (2017).
doi: 10.1093/cid/cix429
pubmed: 28505356
pmcid: 5850568
Moris, P., Jongert E., van der Most R. G. Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine. Hum Vaccines Immunother.14, https://doi.org/10.1080/21645515.2017.1381809 (2018).
Agnandji, S. T. et al. Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in gabonese children vaccinated with RTS,S/AS01E and RTS,S/AS02D. PLoS One.6, https://doi.org/10.1371/journal.pone.0018559 (2011).
Moncunill, G. et al. RTS,S/AS01E malaria vaccine induces memory and polyfunctional T cell responses in a pediatric African phase iii trial. Front Immunol.8, https://doi.org/10.3389/fimmu.2017.01008 . (2017).
Pallikkuth, S. et al. A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses. Elife 9, 1–25 (2020).
doi: 10.7554/eLife.51889
Hill D. L. et al. Immune system development varies according to age, location, and anemia in African children. Sci. Transl. Med.12, https://doi.org/10.1126/scitranslmed.aaw9522 (2020).
Ansong, D. et al. T cell responses to the RTS,S/AS01e and RTS,S/AS02D malaria candidate vaccines administered according to different schedules to Ghanaian Children. PLoS One 6, 1–9 (2011).
doi: 10.1371/journal.pone.0018891
Horowitz, A. et al. Antigen-Specific IL-2 Secretion Correlates with NK Cell Responses after Immunization of Tanzanian Children with the RTS,S/AS01 Malaria Vaccine. J. Immunol. 188, 5054–5062 (2012).
doi: 10.4049/jimmunol.1102710
pubmed: 22504653
Darrah, P. A. et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med 13, 843–850 (2007).
doi: 10.1038/nm1592
pubmed: 17558415
Seder, R. A., Darrah, P. A. & Roederer, M. T-cell quality in memory and protection: Implications for vaccine design. Nat. Rev. Immunol. 8, 247–258 (2008).
doi: 10.1038/nri2274
pubmed: 18323851
Le Gallou, S. et al. IL-2 Requirement for Human Plasma Cell Generation: Coupling Differentiation and Proliferation by Enhancing MAPK–ERK Signaling. J. Immunol. 189, 161–173 (2012).
doi: 10.4049/jimmunol.1200301
pubmed: 22634617
Litjens, N. H. R. et al. IL-2 producing memory CD4+ T lymphocytes are closely associated with the generation of IgG-secreting plasma cells. J. Immunol. 181, 3665–3673 (2008).
doi: 10.4049/jimmunol.181.5.3665
pubmed: 18714042
Hugosson, E. et al. Higher IL-10 levels are associated with less effective clearance of Plasmodium falciparum parasites. Parasite Immunol. 26, 111–117 (2004).
doi: 10.1111/j.0141-9838.2004.00678.x
pubmed: 15279621
Zhang, G. et al. Interleukin-10 (IL-10) polymorphisms are associated with IL-10: Production and clinical malaria in young children. Infect. Immun. 80, 2316–2322 (2012).
doi: 10.1128/IAI.00261-12
pubmed: 22566507
pmcid: 3416471
Swanson, B. J. et al. RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process. Immunity 17, 605–615 (2002).
doi: 10.1016/S1074-7613(02)00456-9
pubmed: 12433367
Conti, P. et al. Expression and secretion of RANTES by human peripheral blood CD4+ cells are dependent on the presence of monocytes. Ann. Clin. Lab Sci. 31, 75–84 (2001).
pubmed: 11314865
Frauenschuh, A. et al. Differential polarization of immune responses by co-administration of antigens with chemokines. Vaccine 23, 546–554 (2004).
doi: 10.1016/j.vaccine.2004.06.024
pubmed: 15530704
Obeng-Adjei, N. et al. Circulating Th1-Cell-type Tfh Cells that Exhibit Impaired B Cell Help Are Preferentially Activated during Acute Malaria in Children. Cell Rep. 13, 425–439 (2015).
doi: 10.1016/j.celrep.2015.09.004
pubmed: 26440897
pmcid: 4607674
The RTS,S Clinical Trials Partnership. A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants. N. Engl. J. Med. 367, 2284–2295 (2012).
The RTS,S Clinical Trials Partnership. First results of phase 3 trial of RTS,S/ AS01 malaria vaccine in African children. N. Engl. J. Med. 365, 1863–1875 (2011).
Sanz, H. et al. drLumi: An open-source package to manage data, calibrate, and conduct quality control of multiplex bead-based immunoassays data analysis. PLoS One 12, 1–18 (2017).
doi: 10.1371/journal.pone.0187901
Clement, F. et al. Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum. Malar. J. 11, 1–15 (2012).
doi: 10.1186/1475-2875-11-384
Therneau, Terry M. Grambsch, P. M. Modeling Survival Data: Extending the Cox Model. Modeling Survival Data: Extending the Cox Model. 1–350 (New York, NY, 2000).